Lynn D. Wilson
From Wikipedia, the free encyclopedia
Lynn Wilson | |
|---|---|
| Citizenship | American |
| Education | Yale School of Medicine |
Lynn D. Wilson is an American radiation oncologist. He is a professor of Therapeutic Radiology and of Dermatology, Executive Vice Chairman, Therapeutic Radiology, and Deputy Chief Medical Officer for Radiation Oncology Services at Yale Cancer Center and Yale School of Medicine in New Haven, Connecticut.[1][2][3]
Wilson earned his medical degree at George Washington University School of Medicine in Washington, D.C., before completing a residency in radiation oncology at Yale New Haven Hospital; he served as a chief resident before joining the Yale School of Medicine faculty in 1994.[4] Prior to his medical degree, Wilson received a master in public health degree, focusing on health services administration, at Yale School of Medicine.[5]
Career
Wilson worked in the laboratory of James B. Mitchell, within the Radiation Biology Branch of the National Cancer Institute/National Institutes of Health (NIH)[6] where he also collaborated with former Commissioner of Food and Drugs Stephen Hahn on journal articles.[7]
Wilson cares for patients with cutaneous lymphoma and breast cancer. His research focus is on outcomes and treatment-related factors for patients receiving radiation for cutaneous lymphoma and has published on radiation therapy for lung cancer as well as on breast cancer.[8] Wilson has served as the director for clinical affairs in the Department of Therapeutic Radiology at Yale since in 2005[9] and was the residency training program director between 2004 and 2013.[6]
From 2011 to 2018, Wilson served on the board of trustees for the American Board of Radiology[10] and was a member of the American Society for Radiation Oncology board of directors from 2016 to 2020.[11]
- He served as the American Society for Radiation Oncology (ASTRO) Chairman of the Scientific Program Committee for their Annual Meetings (2012-2015) At the American Radium Society (ARS) 91st Annual meeting, he was Chair of the Scientific Program Committee (2009).[12]